MOZAIC
TM
What is MOZAIC™?
Our intervention relates to the first discovery in the world to match donors and recipients for fecal microbiota transplantation (FMT) on Clostridium difficile infection (CDI). We have developed a novel, non-invasive stool test using multi-kingdom analyses to help find the best donor for patients with CDI, with a high success rate at over 95%. It can also help reduce the hospitalization time and avoid exposure to antibiotics.
Unmet Need
-
There has been an increasing trend of CDI in the recent two decades
-
The mortality rate of CDI is nearly 60%
-
The recurrence rate after antibiotics therapy against CDI is nearly 50%
-
The success rate of traditional FMT for CDI without donor-receipt matching is low
Features of MOZAIC™
-
World first stool test to match donors and recipients using artificial intelligence
-
Success rate is over 95%
-
High generalizability to other diseases